Menu

• Ask a Health Expert about APPLICATION SITE EXFOLIATION
• Post Your Side Effect related to APPLICATION SITE EXFOLIATION
• APPLICATION SITE EXFOLIATION and FDA Warnings
• APPLICATION SITE EXFOLIATION in Patients Wiki
• Report APPLICATION SITE EXFOLIATION in Drug Side Effect Survey

APPLICATION SITE EXFOLIATION side effect

What is APPLICATION SITE EXFOLIATION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Commit Side Effects Report #5516232-5
Consumer or non-health professional from UNITED STATES reported COMMIT problem on Jan 11, 2007. Female patient, 46 years of age, was treated with COMMIT. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, application site urticaria, application site warmth, malaise, retching, . COMMIT dosage: unknown. During the same period patient was treated with NICORETTE, NICODERM CQ, NICODERM CQ. Patient recovered.

Synagis Side Effects Report #5492703-5
SYNAGIS problem was reported by a Consumer or non-health professional from SOUTH AFRICA on Oct 09, 2007. Female patient was diagnosed with respiratory syncytial virus infection and was treated with SYNAGIS. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, . SYNAGIS dosage: unknown. During the same period patient was treated with PHENOBARBITAL, CAFFEINE CITRATE, CALCIFEROL, ALDACTONE, VIDAYLIN, FERRIMED, MERONEM. Patient recovered.

Duragesic Side Effects Report #5498668-4
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Oct 17, 2007. Female patient, weighting 210.0 lb, was diagnosed with pain, breakthrough pain, complex regional pain syndrome, asthma, bipolar disorder, contraception and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, asthma, bipolar disorder, insomnia, urinary tract infection, . DURAGESIC dosage: unknown. During the same period patient was treated with HYDROCODONE, NEURONTIN, BACLOFEN, ADVAIR DISKUS, FLOVENT HFA, LITHIUM CARBONATE, DEPAKOTE, AVIANE. Patient recovered.

Abreva Side Effects Report #5461503-4
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 26, 2006. Female patient, 77 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, . ABREVA dosage: unknown. Patient recovered.


Abreva Side Effects Report #5462222-0
Consumer or non-health professional from UNITED STATES reported ABREVA problem on May 30, 2007. Female patient, 51 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462758-2
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2007. Female patient, 23 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, application site reaction, erythema, hypersensitivity, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462827-7
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Mar 21, 2007. Female patient, 51 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, application site irritation, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Rebif Side Effects Report #5472404-X
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 27, 2007. Male patient, 25 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, injection site pain, injection site pruritus, injection site reaction, rash, sunburn, . REBIF dosage: unknown. Patient recovered.

Crest Side Effects Report #5757899-6
Consumer or non-health professional from UNITED STATES reported CREST problem on June 03, 2008. Female patient, 64 years of age, weighting 145.5 lb, was treated with CREST. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, tooth discolouration, . CREST dosage: unknown. Patient recovered.


Clean Side Effects Report #5762169-6
CLEAN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2008. Female patient, 35 years of age, weighting 150.0 lb, was diagnosed with acne and was treated with CLEAN. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, scar, . CLEAN dosage: unknown. Patient recovered.

Climara Side Effects Report #5698661-2
Consumer or non-health professional from UNITED STATES reported CLIMARA problem on Jan 19, 2007. Female patient, 52 years of age, was diagnosed with menopausal symptoms prophylaxis and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site exfoliation, . CLIMARA dosage: unknown. During the same period patient was treated with GLUCOPHAGE. Patient recovered.

Climara Side Effects Report #5621482-3
CLIMARA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2007. Female patient, 44 years of age, weighting 116.8 lb, was diagnosed with sleep disorder and was treated with CLIMARA. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site exfoliation, application site mass, . CLIMARA dosage: unknown. During the same period patient was treated with AMBIEN. Patient recovered.

Neupro Side Effects Report #5642021-7
Consumer or non-health professional from GERMANY reported NEUPRO problem on Jan 28, 2008. Male patient, 70 years of age, was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site exfoliation, application site pruritus, . NEUPRO dosage: 6 MG/24H (6 MG/24H 1 IN 1 DAY(S)) TRANSDERMAL. During the same period patient was treated with MADOPAR, LEVODOPA, ENTACAPONE, SOTALOL. Patient recovered.

Efudex Side Effects Report #5493858-9
EFUDEX problem was reported by a Physician from UNITED STATES on Oct 05, 2007. Male patient, 75 years of age, weighting 200.0 lb, was diagnosed with actinic keratosis and was treated with EFUDEX. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site exfoliation, facial palsy, . EFUDEX dosage: unknown. Patient was hospitalized. Patient recovered.


Abreva Side Effects Report #5461371-0
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Sept 27, 2006. Male patient, 37 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site discolouration, application site exfoliation, application site irritation, hypersensitivity, . ABREVA dosage: unknown. Patient recovered.

Daytrana Side Effects Report #5452088-7
DAYTRANA problem was reported by a Pharmacist from UNITED STATES on June 07, 2007. Male patient, weighting 164.7 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with DAYTRANA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site exfoliation, . DAYTRANA dosage: 10 MG, DAILY, TRANSDERMAL; 10+14 MG DAILY, TRANSDERMAL. Patient recovered.

Neosporin Side Effects Report #5773061-5
Consumer or non-health professional from UNITED STATES reported NEOSPORIN problem on May 30, 2008. Female patient, 52 years of age, weighting 180.0 lb, was diagnosed with surgery and was treated with NEOSPORIN. After drug was administered, patient experienced the following problems/side effects: application site burn, application site exfoliation, application site hypersensitivity, application site oedema, application site pain, infection, oedema mouth, rash, . NEOSPORIN dosage: unknown. During the same period patient was treated with PREDNISONE, DIPHENHYDRAMINE. Patient recovered.

Duragesic Side Effects Report #5749290-3
DURAGESIC problem was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2008. Male patient, weighting 260.0 lb, was diagnosed with pain, blood pressure, neuralgia and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site exfoliation, application site irritation, application site pruritus, application site reaction, breakthrough pain, type 2 diabetes mellitus, . DURAGESIC dosage: unknown. During the same period patient was treated with ATENOLOL, ENALAPRIL MALEATE, LASIX, NORVASC, GABAPENTIN, INDOMETHACIN. Patient recovered.

Efudex Side Effects Report #5321779-0
Physician from UNITED STATES reported EFUDEX problem on Apr 24, 2007. Male patient, 75 years of age, weighting 200.0 lb, was diagnosed with actinic keratosis and was treated with EFUDEX. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site exfoliation, facial palsy, . EFUDEX dosage: unknown. Patient recovered.


Voltaren Side Effects Report #5505177-2
VOLTAREN problem was reported by a Consumer or non-health professional from CHINA on Oct 24, 2007. Female patient, 24 years of age, was diagnosed with neck pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, application site erythema, application site exfoliation, application site pruritus, application site swelling, . VOLTAREN dosage: unknown. Patient recovered.

Carac Side Effects Report #5511164-0
Physician from UNITED STATES reported CARAC problem on Nov 05, 2007. Male patient was treated with CARAC. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site erythema, application site exfoliation, application site infection, application site irritation, application site rash, enterococcal infection, pain, . CARAC dosage: unknown. During the same period patient was treated with KURIC, STEROID CREAM NOS, TRIAM, TOPROL, ZYRTEC, ADVAIR DISKUS, MAXZIDE. Patient recovered.

Altabax Side Effects Report #5511281-5
ALTABAX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2007. Male patient, 67 years of age, was diagnosed with wound and was treated with ALTABAX. After drug was administered, patient experienced the following problems/side effects: application site eczema, application site erythema, application site exfoliation, application site irritation, . ALTABAX dosage: unknown. During the same period patient was treated with HYDROGEN PEROXIDE SOLUTION, BANDAGE. Patient recovered.

Carac Side Effects Report #5527851-4
Consumer or non-health professional from UNITED STATES reported CARAC problem on Nov 19, 2007. Male patient was diagnosed with tinea cruris and was treated with CARAC. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site erythema, application site exfoliation, application site infection, application site irritation, application site rash, enterococcal infection, pain, . CARAC dosage: unknown. During the same period patient was treated with KURIC, STEROID CREAM NOS, TRIAM, TOPROL, ADVAIR DISKUS, MAXZIDE, ZYRTEC. Patient recovered.

Carac Side Effects Report #5492927-7
CARAC problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2007. Male patient was treated with CARAC. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site erythema, application site exfoliation, application site infection, application site irritation, application site rash, enterococcal infection, pain, . CARAC dosage: unknown. During the same period patient was treated with KURIC, STEROID CREAM NOS, TRIAM, TOPROL, ZYRTEC. Patient recovered.

Abreva Side Effects Report #5461269-8
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Aug 31, 2006. Female patient, 60 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site discharge, application site exfoliation, application site pain, application site scab, application site swelling, lip swelling, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462615-1
ABREVA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2007. Male patient, 26 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site exfoliation, oral herpes, . ABREVA dosage: unknown. Patient recovered.

Abreva Side Effects Report #5462806-X
Consumer or non-health professional from UNITED STATES reported ABREVA problem on Mar 15, 2007. Female patient, 31 years of age, was treated with ABREVA. After drug was administered, patient experienced the following problems/side effects: application site bleeding, application site dryness, application site exfoliation, . ABREVA dosage: unknown. Patient recovered.

Altabax Side Effects Report #5410977-3
ALTABAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Male patient, 67 years of age, was diagnosed with wound and was treated with ALTABAX. After drug was administered, patient experienced the following problems/side effects: application site eczema, application site erythema, application site exfoliation, application site irritation, . ALTABAX dosage: unknown. During the same period patient was treated with HYDROGEN PEROXIDE SOLUTION, BANDAGE. Patient recovered.

Neupro Side Effects Report #5708749-5
Consumer or non-health professional from GERMANY reported NEUPRO problem on Apr 07, 2008. Male patient was treated with NEUPRO. After drug was administered, patient experienced the following problems/side effects: application site dryness, application site erythema, application site exfoliation, application site pruritus, application site scar, application site vesicles, open wound, . NEUPRO dosage: 4 MG/24H (4 MG/24H 1 IN 1 DAY (S)) TRANSDERMAL. Patient recovered.